Grace Kim | Investor Relations |
Spiro Rombotis | President and Chief Executive Officer |
Mark Kirschbaum | Senior Vice President and Chief Medical Officer |
Paul McBarron | Executive Vice President, Chief Financial Officer and Chief Operating Officer |
Ahu Demir | Ladenburg Thalmann |
Jeff Jones | Oppenheimer |
Kemp Dolliver | Brookline Capital Markets |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals Second Quarter 2023 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. After today’s call members of the financial community will have the opportunity to ask questions. [Operator Instructions] Please note today's call is being recorded.
I would now like to turn the conference call over to the company.